INTRODUCTION
============

Classical biochemistry conducted by Kornberg and co-workers revealed that *Escherichia coli* DNA PolI (polymerase I) contained two readily separable enzymatic activities within the same polypeptide \[[@B1],[@B2]\]. The C-terminal 'Klenow' fragment exhibited DNA polymerase and 3′→5′ 'proofreading' activity, whereas the N-terminal domain accounted for 5′→3′ exonuclease activity. The 5′→3′ exonuclease domain of PolI falls within a wider class of essential metallonucleases, the FEN (flap endonuclease) family \[[@B3]\]. FENs demonstrate both 5′→3′ exonuclease and structure-specific endonuclease activity, playing important roles in DNA replication, repair and recombination \[[@B4]--[@B6]\]. These enzymes are ubiquitous and highly conserved in all three kingdoms of life (Eubacteria, Archaea and Eukaryota), presumably due to their role in these crucial biological processes.

The importance and biological similarity of FENs has been demonstrated in several cross-species studies. In bacteriophage T4, disruption of the *rnh* gene (which encodes a FEN, known historically as T4 RNase H) resulted in slower, less accurate DNA replication. Furthermore, no measurable progeny were recovered from a host carrying a deletion in the PolI 5′→3′ exonuclease domain \[[@B7]\], clearly implicating the essential requirement of an active FEN for viral replication. The lethal phenotype of Δ*rad27* (encoding another FEN homologue) in *Saccharomyces cerevisiae* was suppressed by the PolI 5′→3′ exonuclease domain of *E. coli* \[[@B8]\]. In higher organisms, heterozygous (*Fen1*^+/−^) mice rapidly developed lymphoma and thymic abnormalities, whereas homozygous knockouts (*Fen1*^−/−^) displayed the embryonic lethal phenotype \[[@B9]\]. Moreover, mice with a single point mutation (E160D) in one of the two divalent metal ion-binding sites present in the FEN enzyme were reported to be predisposed to autoimmunity, chronic inflammation and cancers \[[@B10]\].

FENs recognize substrates with a DNA duplex and a single-stranded 5′ overhang such as might arise during strand displacement synthesis. The principle site of hydrolytic phosphodiester backbone cleavage is one nucleotide into the DNA duplex, at the bifurcation of single- and double-stranded DNA \[[@B11]\]. In addition, FENs that play a role in nucleotide excision repair (e.g. XPG in humans) can cleave 'bubble' substrates that have no free 5′ end at the bifurcation of single- and double-stranded DNA. As exonucleases, FENs cleave free 5′ termini and nicked DNA duplexes, liberating mono-, di- and short poly-nucleotides \[[@B12],[@B13]\]. Both endo- and exo-nucleolytic activities are generally accepted to play a role in Okazaki fragment processing during DNA replication \[[@B6]\].

A number of FEN structures have been elucidated using X-ray crystallography. The structures show striking similarities, with a core β-sheet adorned with a number of surrounding α-helices. The FEN domain of *Thermus aquaticus* DNA PolI, T4RNaseH and T5FEN all reveal the presence of at least two divalent metal ion-binding sites \[[@B14]--[@B16]\]. Experimental evidence based on isothermal titration calorimetry and mutagenesis studies support the presence of two metal-binding sites \[[@B17],[@B18]\]. Metal site I is required for generation of an attacking hydroxyl nucleophile during phosphodiester backbone hydrolysis \[[@B19]\]. Metal site II is required for substrate binding, particularly during exonucleolytic cleavage \[[@B17]\]. In T5FEN, a key structural motif is formed from α-helices bridging above the active site has been described as a 'helical arch' \[[@B15]\] or 'helical clamp' \[[@B20],[@B21]\]. This feature has been observed in a number of enzymes, and based on biochemical studies, has been proposed to play a role in substrate binding \[[@B20]--[@B23]\]. Recently, a 3 Å (1 Å=0.1 nm) X-ray diffraction structure of T4 RNase H in complex with a forked DNA substrate was solved \[[@B24]\]. These results were in close agreement with models of FEN substrate interaction previously proposed from site-directed mutagenesis and substrate-binding studies \[[@B25],[@B26]\].

An early interrogation of the incomplete *E. coli* genome sequence identified a putative gene (later termed *xni* \[[@B27]\]) whose product shared significant homology to the PolI 5′→3′ exonuclease domain and other known FENs \[[@B4],[@B28]\]. Shafritz et al. \[[@B27]\] reported the purification and characterization of the product of the *xni* gene. Surprisingly, given the significant homology to a family of enzymes demonstrating 5′→3′ exonuclease activity, the authors suggested that the *xni* product was a 3′→5′ exonuclease and designated the *xni* gene product ExoIX (exonuclease IX) \[[@B27]\]. Recently we have shown that exonuclease III (a 3′→5′ exonuclease) co-purifies with ExoIX over a multiple-stage purification process \[[@B29]\]. Therefore, we suggested that the 3′→5′ exonuclease activity described by Shafritz et al. \[[@B27]\] in ExoIX was due to co-purifying exonuclease III.

Here we show that a number of prokaryotes encode a second FEN paralogue, in addition to that present as an N-terminal domain of PolI. Based on amino acid sequence analysis, these single-domain eubacterial FEN homologues can be delineated into two distinct groups. One group appears to possess binding sites for two divalent metal ions, as observed in all FENs characterized to date. The second group, exemplified by *E. coli* ExoIX, seems to lack a number of normally conserved amino acid residues that act as metal-binding ligands. We demonstrate that, in contrast with ExoIX, which apparently lacks activities expected of a FEN when assayed in isolation, a discrete FEN homologue encoded by *Staphylococcus aureus* has both FEN and 5′γ3′ exonuclease activities. We compare and contrast these two representatives of the cryptic single-domain eubacterial FEN homologues and speculate as to their biological roles.

EXPERIMENTAL
============

Alignments and phylogenetics
----------------------------

DNA PolI paralogues were identified by TBLASTN searches \[[@B30]\] and multiple sequence alignments prepared with CLUSTALW \[[@B31]\], edited in Jalview \[[@B32]\] and annotated by hand. Identified primary motifs were analysed with Pattinprot \[[@B33]\]. A phylogenetic tree was constructed from the alignment using Phylip algorithms \[[@B34]\]. These were defined using default parameters in Protdist and Neighbor-joining clustering \[[@B35]\], followed by radial plots, generated using the Phylemon server (<http://phylemon.bioinfo.cipf.es>) \[[@B36]\].

Secondary and tertiary structural predictions
---------------------------------------------

Structural predictions for *Sa*FEN (*Staph. aureus* FEN) were generated using FUGUE ([http://www-cryst.bioc.cam.ac.uk/∼fugue/prfsearch.html](http://www-cryst.bioc.cam.ac.uk/~fugue/prfsearch.html)) \[[@B37]\] and Phyre ([http://www.sbg.bio.ic.ac.uk/∼phyre/](http://www.sbg.bio.ic.ac.uk/~phyre/)) \[[@B38]\]. The quality of the derived models was checked by eye in the first instance, for the local geometry of strictly conserved residues. A model of *Sa*FEN, docked with a branched substrate, was prepared by superimposition of the Phyre Apo *Sa*FEN model with bacteriophage T4 RNase H in complex with DNA (PDB code 2IHN), using an all atom best-fit algorithm in Deepview (<http://www.expasy.org/spdbv/>) \[[@B39]\], followed by manual rigid body docking of DNA within a 1.5 Å constraint and final remodelling of single-stranded DNA regions to facilitate best fit. Final models were submitted to PROCHECK \[[@B40]\], hosted on the JCSB server (<http://www.jcsg.org/scripts/prod/validation/sv_final.cgi>) for assessment of their stereochemical quality. MolProbity (<http://molprobity.biochem.duke.edu/>) was used for additional checks on the validity of single-stranded DNA remodelling, in comparison with the original DNA template (chain CD, of PDB protein number 2IHN \[[@B24]\]).

Bacterial strains and plasmids
------------------------------

*E. coli* strain M72 pJONEX4*ch* was provided by Dr C. E. Meadows (Department of Infection and Immunity, University of Sheffield, Sheffield, U.K.) and purified genomic DNA from *Staph. aureus* strain 8325-4 was a gift from Professor Simon Foster (Molecular Biology and Biotechnology, University of Sheffield, U.K.). Recombinant bacteriophage T5 FEN and *E. coli* ExoIX were overexpressed and purified as described previously in \[[@B12],[@B29]\].

Cloning recombinant *Staph. aureus fen*
---------------------------------------

PCR was performed using *Staph. aureus* strain 8325-4 genomic DNA template with primers for *MW1329* (forward, 5′-TATTG[AATTCAA]{.ul}AGAAGGAACGTTTAAATGCCT-3′; reverse, 5′-TTTATAC[GGATCC]{.ul}AAAAATGGGATGAAATATATTTTCC-3′), with the restriction site underlined, using the Expand High Fidelity PCR System, according to the manufacturer\'s instructions (Roche Diagnostics GmbH). The gel-purified product was digested with BamHI and EcoRI, ligated into pJONEX4*ch* (a gift from Dr C. E. Meadows) and transformed into electrocompetent *E. coli* M72. Positive clones were confirmed by capillary sequencing on an ABI 3730 instrument (Genetics Core Facility, University of Sheffield). The resulting expression plasmid was designated pJONEX4/*fench*. This plasmid encoded the *Staph. aureus* FEN-like protein as a C-terminal polyhistidine fusion linked via an enterokinase cleavage motif, resulting in the addition of the sequence DDDDKHHHHHH to the C-terminus of the protein.

Preliminary inductions
----------------------

Culture medium {30 ml 2YT/C \[2YT: 1.6% (w/v) tryptone, 1% (w/v) yeast extract and 0.5% (w/v) NaCl; with 100 μg ml^−1^ carbenicillin\]} was inoculated with 1/100 volume (300 μl) of an overnight culture of M72 pJONEX4/*fench*. The culture was grown to an *A*~595~ of 0.5 and induced at 42 °C for 0.5, 1, 1.5 or 2 h duration, followed by incubation at 30 °C, for up to a total of 2 h post-induction (i.e. the 2 h 42 °C culture received no further incubation). A control strain containing the empty vector was grown with continuous heat-shock or without temperature-induction. Cells were harvested and analysed by SDS/10% PAGE using either Coomassie Blue stain or DNase substrate gel assays \[[@B41]\].

Overexpression and purification of *Sa*FEN
------------------------------------------

A fermenter vessel containing approx. 5 litres of 2×YT/C with 0.01% (v/v) antifoam (Sigma) was seeded with a 1/15 inoculum of an overnight culture of M72 pJONEX4/*fench*. The culture was grown to an absorbance of 0.6 (*A*~595~) at ≤30 °C, followed by heat-shock induction at 42 °C for 2 h. The culture was cooled to 25 °C and incubated for a further 4.5 h prior to harvesting. The cell pellet was recovered by centrifugation at 3000 ***g*** for 30 min at 4 °C, washed with 50 mM Tris/HCl, pH 8.0, containing 0.9% (w/v) NaCl and stored in aliquots at −80 °C. Cell pellet (7.5 g) was resuspended in 40 ml of EQ buffer \[25 mM potassium phosphate buffer, pH 7.4, containing 20% (w/v) glycerol, 500 mM NaCl and 30 mM imidazole\]. Lysozyme (200 μg/ml) and sodium deoxycholate (500 μg/ml) were added, and the reaction was incubated on ice for up to 1 h, followed by sonication at 20% maximum amplitude in 10 s bursts. Insoluble material was removed via centrifugation at 35000 ***g*** for 30 min and the supernatant cleared by filtration (Whatman No. 1) to remove residual precipitate, before loading onto a 1 ml HisTrap column (GE Healthcare), equilibrated with EQ buffer at ≤0.5 ml/min. The column was washed in an excess of 30 ml EQ buffer (returning *A*~280~ to baseline), followed by elution over a 15 ml 40--500 mM imidazole gradient, collecting 0.5 ml fractions. Fractions were analysed by SDS/PAGE using Coomassie Blue and zymogram assays for exonuclease activity \[[@B41]\]. Fractions of greatest purity were equilibrated against a 100-fold excess of LSQ buffer \[25 mM Tris/HCl, pH 8.0, containing 5% (w/v) glycerol, 1 mM EDTA and 5 mM DTT (dithiothreitol)\], adjusted to 30% (w/v) ammonium sulphate and incubated for 15 min at room temperature (22 °C). Precipitated material was collected via centrifugation at 4000 ***g*** for 10 min and the buffer adjusted to LSQ Buffer, containing 50% (w/v) glycerol, for storage at −20 °C.

Nuclease assays
---------------

Structure-specific nuclease assays were performed using oligonucleotides synthesized by MWG Biotech AG ([Table 1](#T1){ref-type="table"}) and purified by butanol precipitation \[[@B42]\]. Oligonucleotides were radiolabelled in a reaction (30 μl) containing 5 pmol DNA, \[1×\] kinase buffer (70 mM Tris/HCl, pH 7.6, 10 mM MgCl~2~, 5 mM DTT), 6 pmol \[γ-^32^P\]ATP and 30 units of polynucleotide kinase at 37 °C for 1 h, and quenched by the addition of an equal volume of stop-mix \[95% deionised formamide, 10 mM EDTA and 0.05% (w/v) Bromophenol Blue. Labelled oligonucleotides were purified using a QIAquick Nucleotide Removal Kit (Qiagen Ltd) and quantified by comparison with a serial dilution of \[γ-^32^P\]ATP using a BioRad Personal FX phosphorimager. Substrates for structure-specific assays were formed in annealling reactions (200 μl) containing 450 pM \[γ-^32^P\]-labelled DNA and 13.5 nM unlabelled complementary oligonucleotide(s), in a buffer comprising 25 mM Tris/HCl, pH 8.0 and 500 mM KCl, incubated at 80 °C for 5 min and passively cooled to ambient temperature. Standard nuclease reactions (10 μl) were performed with 3 μl of annealed labelled oligonucleotide, 5 μl of 2×reaction buffer (50 mM Tris/HCl, pH 8.0, 200 mM KCl, 20 mM MgCl~2~ and 0.6 mg/ml acetylated BSA), and 2 μl of enzyme prepared in enzyme dilution buffer \[25 mM Tris/HCl, pH 8.0, containing 10% (w/v) glycerol, 1 mM EDTA, 1 mM DTT and 1 mg/ml acetylated BSA\]. The final mixture, which contained 100 nM enzyme and 135 pM radiolabelled oligonucleotide was incubated at 37 °C for 30 min before the reaction was quenched by the addition of an equal volume of stop-mix. Reaction products were analysed by denaturing PAGE (15% 19:1 acrylamide: bisacrylamide) \[[@B42]\]. In addition to the structure-specific nuclease assays described above, an exonuclease assay was deployed based on that described by Fraser \[[@B43]\]. This assay used high-molecular-mass DNA as a substrate. Exposure to exonuclease releases acid soluble mononucleotides and polynucleotides from acid-precipitable substrate. Release of acid-soluble products was monitored by UV spectroscopy after incubation with perchloric acid and centrifugation as described in \[[@B29]\].

###### Oligonucleotides used in structure-specific nuclease assays, presented in [Figure 4](#F4){ref-type="fig"}

Substrates were prepared as described in the Experimental section. In brief, unlabelled oligonucleotides were present at a 30-fold excess (13.5 nM) when annealed to the complementary radiolabelled strand (450 pM). Radiolabelled oligonucletides are *italicised* and the labelled 5′ terminal nucleotides are indicated in bold typeface.

  Sequence                                                       Reference           Used in [Figure 4](#F4){ref-type="fig"} panel
  -------------------------------------------------------------- ------------------- -----------------------------------------------
  *5*′-*d(*\****G****ATCCTAACTGGGGTTCAGAATCC)*                   The present study   **A**--**G**
  5′-d(GGATTCTGAACCCCAGTTAGGATC)                                 The present study   **B**
  5′-d(GGATTCTGAACCCCAGTTAGGATCTCGGATCCTGTA)                     The present study   **C**
  5′-d(TCGGATCCTGTAGGATTCTGAACCCCAGTTAGGATC)                     The present study   **D**
  5′-d(TACAGGATCCGA)                                             The present study   **C** and **D**
  5′-d(GGATTCTGAACCCC)                                           The present study   **E**
  5′-d(GGATTCTGAACCCCGACGGTAGTCAACGTG)                           The present study   **F** and **G**
  5′-d(CACGTTGACTACCGTC)                                         The present study   **G**
  *5*′-*d(*\****A****GTCTAGACTGCAGTTGAGTCCTTGCTAGGACGGATCCCT)*   \[[@B49]\]          **H**, **I** and **J**
  5′-d(AGGAATTCAACCACCGCTCAACTCAACTGCAGTCTAGACT)                 \[[@B49]\]          **I** and **J**
  5′-d(AGGGATCCGTCCTAGCAAGGGGCTGCTACCGGAAGCTTCT)                 \[[@B49]\]          **H** and **J**
  5′-d(AGAAGCTTCCGGTAGCAGCCTGAGCGGTGGTTGAATTCCT)                 \[[@B49]\]          **H** and **I**

RESULTS AND DISCUSSION
======================

Delineation of eubacterial FENs
-------------------------------

We originally identified the gene now known as *xni* by homology searches of the sequence databases in 1994 \[[@B4],[@B28]\]. The *xni* gene encodes ExoIX, a paralogue of the N-terminal FEN domain of DNA polymerase I. The defining feature of all the eubacterial FEN family is a highly conserved cluster of carboxylate ligands at the putative active site (Supplementary Figure S1 at <http://www.BiochemJ.org/bj/418/bj4180285add.htm>). In *Ec*ExoIX (*E. coli* ExoIX), these are Asp^10^, Asp^51^, Glu^103^, Asp^105^ and Asp^128^. A key feature of the *Ec*ExoIX polypeptide sequence is the absence of certain aspartic acid residues, conserved in previously characterized FENs ([Figure 1](#F1){ref-type="fig"}A). These conserved residues form the ligands that co-ordinate one of two divalent metal ions, directly observed in several FEN crystal structures \[[@B14]--[@B16]\]. *Ec*ExoIX possesses the conserved aspartates which make up the high affinity catalytic metal-binding site, known as site I \[[@B17]\]. However, the multiple sequence alignment ([Figure 1](#F1){ref-type="fig"}) reveals that key aspartate residues, normally involved in binding the second divalent metal ion in classical FENs, have been replaced by the small side chains of Gly^130^, Ser^175^, and the aliphatic residue Ile^178^, in *Ec*ExoIX (boxed residues in [Figure 1](#F1){ref-type="fig"}A). These residues are unable to chelate a divalent metal ion. Indeed, when only two of the analogous mutations (D201I and D204S) were introduced into T5FEN, the resulting mutant lost its ability to bind metal at site II \[[@B17]\] as well as much of its potency as an exonuclease. However, the structure-specific endonuclease activity of the T5FEN D201I/D204S mutant remained intact. The metal site II substitutions form a striking motif that delineates the ExoIX subset from the wider FEN family of polypeptides ([Figure 1](#F1){ref-type="fig"}B and Supplementary Figure S1).

![Evaluation of eubacterial DNA PolI 5′-3′ exonuclease paralogues\
(**A**) ClustalW multiple sequence alignment of 5′-3′-like nucleases with their related Pol I paralogues. Both classes of eubacteria contain two putative paralogous FEN-like proteins, one associated with the Klenow fragment in the form of DNA Pol I (*polA*), and the other encoded autonomously. The autonomous FEN-like proteins can be divided into those which retain all the putative ligands to bind two metal ions (e.g. *Sa*FEN) and those which retain the ligands to bind a single divalent metal ion (*Ec*ExoIX). Perfectly conserved residues are boxed in grey. The amino acid substitutions affecting binding at the second metal site in ExoIX are shown in clear boxes. (**B**) Phylip radial phylogenetic tree, derived from ClustalW alignment of 19 secondary FENs from eubacteria (Supplementary Figure S1). A clear differentiation of ExoIX and FEN classes is evident. Eubacterial paralogous FENs fall into two discrete classes with predicted affinity for one (hatched area) or two (grey area) metal ions. This broadly, but not exclusively, correlates with Gram-positive and -negative classification (bold and underlined type respectively).](bic378i001){#F1}

Our sequence analysis revealed a further class of FEN paralogues. We observed a subset encoding short FEN-like proteins that retain all the conserved aspartic acid residues associated with both metal sites I and II. This subset encoded FEN-like proteins that were independent of the N-terminal FEN domains found in DNA PolI orthologues. [Figure 1](#F1){ref-type="fig"}(A) shows exemplars of the two subsets of autonomous FEN-like proteins. The *Sa*FEN represents those containing all the conserved features of the FENs, whereas *Ec*ExoIX represents those lacking the aspartates necessary for binding metal site II. Phylogenetic analysis reveals that ExoIX and FEN fall broadly, though not exclusively, in classification based on Gram type ([Figure 1](#F1){ref-type="fig"}B). Here we analysed 19 previously identified PolI FEN paralogues \[[@B44]\], performing ClustalW multiple alignments (Supplementary Figure S1) to generate a phylogenetic tree ([Figure 1](#F1){ref-type="fig"}B).

In our analysis we also observed another intriguing class of PolI FEN paralogues in the marine bacteria *Shewanella* sp. and *Colwellia* sp. These organisms appear to fall at the divergent branch point between autonomous eubacterial FEN and ExoIX subsets ([Figure 1](#F1){ref-type="fig"}B). They retain more conserved residues than *Ec*ExoIX (*Colwellia* sp., Gly^150^, Asp^195^ and Asn^198^) in place of typical FEN site II aspartate ligands. Based on site-directed mutagenesis in T4 RNase H and other FENs, we suggest these gene products would be likely to exhibit diminished enzymatic activity \[[@B22]\].

We tentatively suggest that prokaryotes can be classified into four groups based on the number and type of FEN homologue that they encode: (i) a FEN only as an N-terminal domain of DNA PolI, as exemplified in *Streptococcus pneumoniae*; (ii) N-terminal DNA PolI with a separate FEN paralogue with one divalent metal-binding site, e.g ExoIX in *E. coli*; (iii) N-terminal DNA PolI with a separate FEN paralogue with two divalent metal-binding sites, e.g. *Staph. aureus*; and (iv) a Klenow-like PolI domain (with no attached FEN domain) and a separate FEN domain with two divalent metal ion-binding sites, as exists in *Mycoplasma genitalium (*NP_072928). Accordingly, we therefore propose a more precise nomenclature for prokaryotic FEN-like genes, to allow for this simple but important distinction. The gene name *xni* should be used to specify the subset containing only the site I carboxylate ligands (i.e. those genes encoding ExoIX orthologues). The gene *fen* should specify all other homologues, whether carried alongside *polA* or as the sole chromosomal copy. We support this proposition with the following biochemical analysis of the *Staph. aureus fen* gene product.

*Staph. aureus fen* encodes an active nuclease
----------------------------------------------

Based on the retention of a full complement of metal-binding aspartyl ligands, we reasoned that the newly identified Staphylococcal enzyme should display similar structure-specific endo- and exo-nucleolytic activities to previously identified FENs. We cloned and expressed *Staph. aureus fen* under the control of the temperature-inducible bacteriophage λ P~L~ promoter in the pJONEXCH expression vector \[[@B45]\]. The recombinant protein was expressed with a C-terminal polyhistidine tag. [Figure 2](#F2){ref-type="fig"}(A) shows the properties of the recombinant *Sa*FEN protein in preliminary inductions. A distinct band of the anticipated molecular mass (35 kDa) was induced upon heat-shock (0.5--2 h) but was absent in control lysates (−/+,0 h). Furthermore, using an *in situ* zymogram assay we observed a co-induced nuclease activity, under conditions of heat shock ([Figure 2](#F2){ref-type="fig"}A, panel ii), with some evidence of proteolysis. The protein was purified to \>95% homogeneity ([Figure 2](#F2){ref-type="fig"}B, panel i). Zymogram assays confirmed that the DNase activity shared chromatographic and physicochemical properties with the induced *Sa*FEN protein ([Figure 2](#F2){ref-type="fig"}B, panel ii). These data show that the novel *Staph. aureus fen* gene encodes a *bona fide* nuclease. The nuclease activity required divalent metal ions as expected and was not adversely affected by the C-terminal fusion (results not shown). We also obtained very similar zymogram data for an untagged version of the *Sa*FEN protein, but it proved difficult to purify without the affinity tag, unlike the untagged T5FEN and ExoIX (results not shown).

![SDS/10% PAGE analysis of recombinant *Staph. aureus* FEN\
(**A**) Heat-shock induction (0--2 h at 42 °C) of recombinant *Sa*FEN demonstrates protein of the anticipated molecular mass (35 kDa; black arrow); i) stained with Commassie Blue or ii) zymogram for DNase activity. (**B**) Fractions taken during the purification of *Sa*FEN were analysed by SDS/10% PAGE and stained with i) Coomassie Blue or ii) a zymogram assay of DNase activity. A replicate gel was prepared with 40 μg/ml of Type XIV herring sperm DNA, and assayed for *in situ* DNase activity, furnished with 10 mM MgCl~2~ as cofactor \[[@B41]\]. M, Marker (BioRad precision unstained), molecular mass of standards is given in kDa; TL, total lysate; SE, soluble extract; Ch, pooled Ni-chelate eluate; AS; ammonium sulphate precipitated fraction (final 30% saturated).](bic378i002){#F2}

Comparison of *Sa*FEN with other FEN family members
---------------------------------------------------

Using a standard spectrophotometric assay, we quantified the exonucleolytic activity of purified *Sa*FEN against the well-characterized control FEN T5FEN ([Figure 3](#F3){ref-type="fig"}). This has proven to be a simple, highly reproducible and robust assay, in the characterization of other FENs \[[@B12],[@B23],[@B29]\]. Under similar experimental conditions (pH 8.0 at 37 °C), the specific activity for T5FEN, calculated in a previous study (610 units/μg) \[[@B29]\] was similar to that reported in the present study (420±10 units/μg), The specific activity of *Sa*FEN (90±5 units/μg) was approx. 5-fold lower than that of T5FEN, equivalent to a turnover rate of 106 min^−1^. T5FEN is a highly processive exonuclease, which serves as a stringent control. By comparison, the reported turnover of *E. coli* Pol I FEN under similar assay conditions is 37 min^−1^ (37 °C, pH 7.4) \[[@B2]\]. Thus, the activity of *Sa*FEN is approx. 3-fold greater than *E. coli* PolI FEN activity under similar conditions, suggesting that the activity of the novel polypeptide is biologically relevant. As reported previously, ExoIX showed no detectable activity under any assay conditions tested \[[@B29]\].

![Comparison of exonucleolytic properties of prokaryotic FEN homologues\
Release of acid-soluble nucleotides (nmol) in a standard reaction (1 ml) at pH 8.0, containing an excess of type XIV herring sperm DNA substrate, measured spectrophotometrically and adjusted to 1 μg of protein to aid comparison: ExoIX (▲), *Sa*FEN (□), T5FEN (◊). Mean values from three independent readings were plotted, shown ±S.E.M (error bars). Nucleotide release was determined as described elsewhere \[[@B12]\].](bic378i003){#F3}

Structure-specific activity of *Sa*FEN and *Ec*ExoIX
----------------------------------------------------

We hypothesized that the alterations in the predicted active sites of the two classes of divergent FENs would lead to pronouncedly different catalytic activity. To test this, we employed a substrate screen formed from partial or completely complementary oligonucleotides ([Table 1](#T1){ref-type="table"}). The catalytic activity of the proteins was examined for exo- and endo-nucleolytic cleavage under denaturing PAGE ([Figure 4](#F4){ref-type="fig"}).

![Comparison of enzymes\' structure-specific nucleolytic cleavage on a selection of exo- and endo-nuclease substrates\
An excess of enzyme (100 nM) was incubated with preformed 5′-labelled substrate (135 pM) in the presence of 10 mM MgCl~2~, at 37 °C for 30 min, and the reactions analysed on denaturing 15% PAGE. Filled triangles (▼) denote structure-specific endonucleolytic cleavage products and open triangles (∇) exonucleolytic cleavage products. -ve, negative control (BSA carrier, no enzyme); T5, bacteriophage T5 FEN; Sa, *Sa*FEN; IX; *EcE*xoIX. See [Table 1](#T1){ref-type="table"} for explanation of substrates used in **A** **J**.](bic378i004){#F4}

Single-stranded and fully duplexed DNA substrates were cleaved exonucleolytically by *Sa*FEN, liberating products of the same electrophoretic mobility as those released from T5FEN, albeit to a lesser extent ([Figures 4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B). The enzyme also liberated exo-product (≤4 mer) from the 5′ terminus of the downstream strand of a nicked DNA strand. Under the conditions tested, all substrate was degraded ([Figure 4](#F4){ref-type="fig"}C). The nicked substrate (36 mer) was larger than the duplex DNA (24 mer), though this difference is unlikely to account for the heightened activity on the former substrate. This is supported by the similar substrate turnover of the strand upstream of a nick, compared with purely duplex DNA (compare [Figure 4](#F4){ref-type="fig"}D with 4B). These data suggest that *Sa*FEN favours a free 3′ terminus, upstream of the free 5′ end, which perhaps facilitates loading of the enzyme onto the DNA substrate. In this assay the activity of *Sa*FEN was apparently equivalent to T5FEN. Such activity correlates with the involvement of this class of proteins in nick translation \[[@B46]\].

Although SaFEN did not endonucleolytically hydrolyse a 5′ DNA overhang, 5′ PsY (pseudo-Y) and 3′ Inv (invader) bifurcations were cleaved by the staphylococcal enzyme ([Figures 4E--4G](#F4){ref-type="fig"}). On PsY and Inv substrates, *Sa*FEN exhibited both endo- and exo-nucleolytic cleavage, the products of which corresponded to decamers (closed triangle) and tetramers (open triangle). Interestingly, a free 5′ flap of a partially formed junction ([Figure 4](#F4){ref-type="fig"}H) was not hydrolysed by *Sa*FEN. This structure resembled the double flap substrate used in the early characterization of human FEN \[[@B47]\]. In those assays, human FEN cleaved the 5′ flap of double flap structures efficiently, when 3′ overlaps of up to 10 nucleotides were tested. T5FEN cut the large double flap substrate at a number of sites, the most prominent product of which was a 20 mer, formed from hydrolysis at the bifurcation junction. The complex cleavage pattern with this substrate is probably due to transient base pairing, causing the formation of substrates with different free 5′ arms.

The length of duplex DNA also appears to play a role in cleavage efficiency. This hypothesis is supported by the cleavage properties on the double-stranded DNA region of larger (20 bp) Holliday junction intermediates ([Figures 4](#F4){ref-type="fig"}I and [4](#F4){ref-type="fig"}J). Duplex DNA regions of partially formed junctions were hydrolysed more efficiently than shorter substrates (3′ PsY and 5′ Inv substrates, results not shown), with comparable activity to all duplex DNA ([Figure 4](#F4){ref-type="fig"}B). *Sa*FEN activity was limited to exonucleolytic degradation of duplex DNA in Holliday junction intermediates.

In contrast to *Sa*FEN, ExoIX did not demonstrate FEN activity when incubated with a range of substrates ([Figure 4](#F4){ref-type="fig"}). Therefore, ExoIX (when assayed in isolation) did not possess either 5--3′ exonuclease or 5′ FEN activity that would be expected of a FEN enzyme. We hypothesize that the lack of observable characteristic FEN activity is due to the absence of a divalent metal ion-binding site II in this protein.

Modelling cofactor and substrate interactions of *Sa*FEN
--------------------------------------------------------

We used a structural bioinformatics approach to gain insight into the catalytic differences observed in the different FEN homologues characterized above ([Figure 5](#F5){ref-type="fig"}). Using a co-ordinated approach of different structural prediction algorithms, we were able to ascertain with confidence the probable structure of the newly identified staphylococcal enzyme (FUGUE *z*-score 43.6, where ≥6 represents 99% confidence \[[@B37]\]). A Phyre-generated model was used for analysis based on its favourable structural constraints \[[@B38]\]. The model bore striking resemblance to many experimentally derived FEN structures, most notably at the DNA-binding H3TH (helix-three-turn helix) motif and the putative active site ([Figures 5](#F5){ref-type="fig"}A and [5](#F5){ref-type="fig"}B). The model reveals that both divalent metal-binding sites are present in *Sa*FEN, whereas metal site II ligands are absent in ExoIX. We postulate this accounts for the different catalytic activities observed in our screen when the Staphylococcal enzyme was compared to ExoIX. Comparison of this threaded model with other FEN family members revealed a smaller arch domain than that found in T5FEN. The first co-crystal structure of a FEN in complex with a bifurcated substrate has recently been solved \[[@B24]\]. We sought to use this as a model to understand the behaviour of *Sa*FEN in its activity on a similar PsY substrate assayed above (Figure 5C; compare with [Figure 4](#F4){ref-type="fig"}F). The restricted arch of the *Sa*FEN model could still allow DNA to thread though upon interaction with a branched substrate, positioning the scissile phosphate diester close to the site I metal binding site, which is known to be essential for catalysis in the FENs \[[@B17],[@B18]\]. The more restricted arch present in *Sa*FEN may account for the slightly different cleavage pattern it exhibits compared to the T5FEN ([Figure 4](#F4){ref-type="fig"}).

![Homology modelling *Sa*FEN in complex with M^2+^ cofactor and a branched PsY DNA substrate\
Bacteriophage T5FEN (PDB 1UT8) served as a template for the Phyre-threaded model of *Sa*FEN \[[@B38]\], confirmed by two independent algorithms and structural validation (refer to Experimental section). (**A**) Cartoon representation of *Sa*FEN. α-helices are blue and β-sheets are yellow. The DNA-binding H3TH motif is illustrated in white and the predicted active site region is boxed, shown in detail in (**B**). Perfectly conserved eubacterial FEN residues include tyrosine and lysine, in addition to a cluster of carboxyl ligands at the active site, here modelled with two Mn^2+^ ions (cyan spheres). The ligand substitutions affecting site II in the ExoIX sub-class are in brackets. (**C**) A branched DNA substrate was modelled by rigid body docking, based on structural superimposition of the *Sa*FEN model with PDB protein number 2IHN, and steric clashes are reduced to within 1.5 Å. The free 5′ end (in gold) fits best with a threading model, as originally proposed for T5FEN \[[@B15]\], although the arch is disordered and more spatially constricted in *Sa*FEN.](bic378i005){#F5}

Biological role of the cryptic FEN-like proteins
------------------------------------------------

The gene now known as *xni* was initially designated *exo* by this laboratory. It was speculated at the time that the gene might encode a backup function for the FEN-domain of PolI \[[@B28]\]. This inference was initially undermined by the observation that *Strep. pneumoniae polA* null mutants are non-viable \[[@B48]\]. However, this organism does not encode an additional FEN-like protein. Recently, Fukushima et al. \[[@B44]\] demonstrated that the FEN-domain encoded by either *polA* or *xni* was required for the viability of *E. coli*. Similarly, they also showed that either polA or ypcP is essential for *Bacillus subtilis*. The *ypcP* gene encodes a two-metal-site FEN that shares 48% identity and 64% similarity to *Sa*FEN (Supplementary Figure S1). Thus, it would appear that either subclass of the single domain FEN-like proteins discussed here acts in redundancy with DNA PolI. The actual biochemical activity of the *xni*-encoded proteins remains elusive, as we were unable to identify any nucleolytic activity when tested in isolation in biochemical assays, despite testing a wide range of substrates and cofactors. Interestingly, amino acid sequence alignments also suggest that the helical arch motif identified as being important in FEN--substrate interactions is truncated in *Ec*ExoIX, which may be an additional factor in the lack of expected nuclease activity. Perhaps the ExoIX-type proteins need to be part of a complex of protein(s) to display nuclease activity or require some as yet unidentified cofactor. Alternatively, it could be that they process some form of unusual nucleic acid structure.

However, it is clear from genetic experiments and their widespread occurrence that these small FEN-like proteins are capable of fulfilling a critical biological role. The reasons why each group of organisms has retained FEN-like proteins with differing properties is unclear and will require further investigation in to how these proteins participate in biological processes.
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